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Aims: In this  work, we  studied the mechanisms  by
which diphenyleneiodonium chloride (DPI) inhibits
nitric  oxide  (NO)  synthesis  induced  by  the  pro-
inflammatory  cytokine  interleukin-1b (IL-1)  in
bovine  articular  chondrocytes.  To  achieve  this,  we
evaluated the ability of DPI to inhibit the expression
and  activity  of  the  inducible  isoform  of  the  NO
synthase (iNOS) induced by IL-1. We also studied the
ability of DPI to prevent IL-1-induced NF-k B activation
and reactive oxygen species (ROS) production.
Results: Northern and Western blot analysis, respec-
tively,  showed that  DPI  dose-dependently inhibited
IL-1-induced  iNOS  mRNA  and  protein  synthesis  in
primary  cultures  of  bovine  articular  chondrocytes.
DPI effectively inhibited NO production (IC50 = 0.03 ±
0.004 m M),  as  evaluated  by  the  method  of  Griess.
Nuclear  factor-kappa  B  (NF-k B)  activation,  as  eval-
uated  by  electrophoretic  mobility  shift  assay,  was
inhibited  by  DPI  (1Ð10 m M)  in  a  dose-dependent
manner.  IL-1-induced  ROS  production,  as  evaluated
by measurement of dichlorofluorescein fluorescence,
was  inhibited  by  DPI  at  concentrations  that  also
prevented NF-k B activation and iNOS expression.
Conclusions: DPI inhibits IL-1-induced NO production
in chondrocytes by two distinct  mechanisms: (i) by
inhibiting NOS activity, and (ii)  by preventing iNOS
expression through the blockade of NF-k B activation.
These results also support the involvement of reactive
oxygen species in IL-1-induced NF-k B activation and
expression of NF-k B-dependent genes, such as iNOS.
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Introduction
Interleukin-1b (IL-1), a potent pro-inflammatory cyto-
kine,  has  been  detected  at  elevated  levels  in  the
synovial  fluid  of  patients  with  various  forms  of
arthritis.1,2 This cytokine has been shown to inhibit
the synthesis of cartilage matrix proteins,3,4 as well as
to  induce  chondrocytes  to  produce  matrix  metal-
loproteinases5 and inflammatory mediators, such as
prostaglandins6 and nitric oxide (NO).7
The  large  amounts  of  NO  produced  by  chon-
drocytes in response to IL-1 result from activation of
the gene  expression and synthesis of the inducible
isoform of the enzyme  NO synthase (iNOS).7,8 The
iNOS  protein  synthesis  is  mainly  regulated  at  the
transcriptional level and the promoter region of the
iNOS gene from different species has been reported
to  contain  binding  sites  for  several  transcription
factors, including nuclear factor-kappa B (NF-k B).9,10
In most cell types, this transcription factor seems to
be  an  essential  requirement  for  iNOS  induction  in
response to pro-inflammatory cytokines, such as IL-1
and tumor necrosis factor-a (TNF-a ).11–13 Inhibitors
of NF-k B activation have been used to prevent iNOS
expression  and  the  subsequent  NO  production  in
response to a variety of stimuli.10,14
Several lines of evidence suggest that NO plays a
significant  role  in  the  pathogenesis  of  arthritis.  In
humans,  the  production  of  nitrite  (the  stable  end-
product of NO) has been shown to be higher in the
serum and synovial fluid from patients with rheuma-
toid arthritis and osteoarthritis than in age- and sex-
matched controls.15 Inhibitors of NO production have
been  shown  to  effectively  reduce  the  severity  of
inflammatory arthritis and osteoarthritis induced in
animals.16–20At the cellular level, NO has been shown
to mediate some of the catabolic responses induced
by  IL-1  in  chondrocytes;  namely,  suppression  of
proteoglycan  synthesis,4 induction  of  apoptosis,21
activation  of  collagenase  gene  expression,22 and
inhibition of cell proliferation.23
Diphenyleneiodonium  chloride  (DPI)  selectively
inhibits flavonoid-containing enzymes by irreversibly
binding to the flavin moiety of those enzymes, such as
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NADH oxidase, quinone oxidoreductase, cytochrome
P450 reductase and NOS.24–28 DPI has also been shown
to suppress the expression of several genes induced by
inflammatory  cytokines  in  different  cells.  In  chon-
drocytes, for instance, DPI inhibited IL-1-induced c-fos
and collagenase  expression,22 whereas in  mesangial
cells it was found to inhibit NF-k B activation and the
expression of the group IIA phospholipase A2 induced
by IL-1 and tumor necrosis factor-a .29
The present study aimed at elucidating the intra-
cellular  mechanisms  by  which  DPI  inhibits  NO
production induced by IL-1 in articular chondrocytes.
The  ability  of  DPI  to  prevent  IL-1-induced  iNOS
expression and activity was investigated using primary
cultures of bovine articular chondrocytes. To further
characterize these cellular events, the ability of DPI to
inhibit  IL-1-induced  NF-k B  activation  and  reactive
oxygen species (ROS) production was also evaluated.
Material and methods
Chemicals
Recombinant human IL-1b was purchased from R&D
Systems (Abingdon, UK). DPI was from Calbiochem
(San  Diego,  CA,  USA). The  anti-iNOS  antibody  was
from Transduction Laboratories (Lexington, KY, USA).
The anti-p65 antibody was from Serotec Ltd (Oxford,
UK).  The  horseradish  peroxidase-conjugated  anti-
rabbit  antibody  was  from  Dako A/S  (Copenhagen,
Denmark).  The  anti-actin  antibody  was  from
Boehringer  Mannheim  (Mannheim,  Germany).  The
isotopes were from Amersham Pharmacia Biotech Inc.
(Piscataway,  NJ,  USA).  The  oligonucleotide  probe
containing the specific consensus binding sequence
for NF-k B  was from Santa Cruz Biotechnology, Inc.
(Santa  Cruz,  CA,  USA).  29 ,79 -Dichlorodihydrofluor-
escein  diacetate  (DCFH2-DA)  was  purchased  from
Molecular Probes Inc. (Eugene, OR, USA).
Isolation and cell culture
Chondrocytes  were  isolated  from  bovine  articular
cartilage  as  described  previously.30 The  cells  were
plated  at  2 ´ 106 cells/ml  in  Ham’s  F-12  medium
containing 3% antibiotic/antimycotic solution and 5%
fetal bovine serum. The cells were allowed to recover
for 24h at 37°C in a humidified atmosphere supple-
mented with 5% CO2.  Prior to any treatments, the
cells  were  serum-starved  overnight  and,  thereafter,
maintained  in  culture  medium  with  1%  antibiotic/
antimycotic solution and without serum.
Northern blot analysis
Total RNA was isolated with the Trizol reagent (Gibco
Brl,  Grand  Island,  NY,  USA),  and  quantitated  by
spectrophotometry at 260nm. Denatured RNA sam-
ples (20 m g) were analyzed by gel electrophoresis in a
1%  denaturing  agarose  gel,  transferred  to  a  nylon
membrane  and  cross-linked by  heating  at  80°C  for
30min. The  blots  were  hybridized  with  32P-labeled
iNOS c-DNA probe, subsequently stripped and repro-
bed with  32P-labeled  glyceraldehyde  dehydrogenase
c-DNA  as  an  internal  standard to  insure  a  roughly
equal loading. The c-DNA probes were labeled with
[a -32P]dCTP  by  the  klenow  fragment  using  the
Random Primed DNA Labeling  kit from  Boehringer
Mannheim GmbH.
Preparation of cytoplasmic and nuclear extracts
The cells were lysed in 400m l of buffer 1 (10 mM of
Tris-HCl,  10 mM  of  NaCl,  3 mM  of  MgCl2,  0.5%
Nonidet P-40, inhibitors cocktail at 1 : 7 dilution; pH
7.5) and incubated on ice for 15min. The lysates were
centrifuged  at  2300  ´ g/5min/4°C  and  the  super-
natants  (cytoplasmic  extracts)  were  collected  and
stored  at  –70°C. The  pellets  were  resuspended  in
30 m l of buffer 2 (20 mM of HEPES, 5 mM of MgCl2,
0.2 mM of ethylenediamine tetraacetic acid, 1 mM of
dithiothreitol (DTT), 300 mM of NaCl, 20% Glycerol,
inhibitors cocktail at 1 : 7 dilution; pH 7.5). After a
20min  incubation  on  ice,  the  pellet  lysates  were
centrifuged at 18,000 ´ g/20min/4°C and the super-
natants (nuclear extracts) were collected and stored
at –70°C. The protein concentration of the extracts
was measured using  the  bicinchoninic acid/copper
(II) sulfate protein assay kit (Sigma Chemical Co., St.
Louis, MO, USA).
Western blot analysis
The cytoplasmic extracts (25 m g protein) were boiled
in sodium dodecylsulfate (SDS) sample buffer (2.5%
SDS, 0.0625M Tris-HCl, 10% glycerol, 5% 2-mercaptoe-
thanol, 0.05% bromophenol blue; pH 6.8).  The proteins
were separated by SDS-polyacrylamide gel electropho-
resis and transferred onto polyvinylidene  difluoride
(PVDF)  membranes  by  electroblotting.  The  mem-
branes were blocked with 5% skim milk in  Tris-buffered
saline-Tween (TBS-T) (20 mM of Tris-HCl, 150 mM of
NaCl, 0.1% Tween-20) and then probed with the anti-
iNOS antibody.  After washing with  TBS-T, the blots were
incubated with a horseradish peroxidase-conjugated
anti-rabbit antibody. The protein–antibody complexes
were  visualized  by  chemiluminescence  using  the
ECL™  Western  blotting  detection  reagents  from
Amersham Pharmacia Biotech Inc. The  membranes
were subsequently stripped and reprobed with an anti-
actin antibody to ensure an equal protein loading.
Electrophoretic mobility shift assay
The  double-stranded  NF-k B  oligonucleotide  probe
was end-labeled with [g -32P]adenosine triphosphate
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a  Sephadex  G-50  spin  column.  Nuclear  extracts
(10 m g of protein) were incubated for 40min at 4°C in
20 m l  of  binding  reactions  containing  20 mM  of
HEPES, 50 mM of  KCl, 1 mM of MgCl2,  0.5 mM  of
DTT,  4%  Ficoll  400,  2 m g  of  poly(dIdC),  20 m g  of
bovine  serum  albumen  (pH  7.9)  and  200,000cpm/
reaction of [g -32P]-labeled oligonucleotide probe. The
DNA–protein  complexes  were  resolved  by  electro-
phoresis on 4% native polyacrylamide gels. The DNA–
protein complexes in the dried gel were visualized by
autoradiography.  For  supershift  analysis,  nuclear
extracts  were  incubated  on  ice  for  2h  with
2 m g/reaction of anti-p65  antibody,  before the addi-
tion of the radiolabeled oligonucleotide.
Measurement of NO production
NO production was measured as the amount of nitrite
released into the culture supernatant. Nitrite concen-
tration  was  determined  in  cell-free  culture  super-
natants using the spectrophotometric method based
on the Griess reaction.31
Assessment of cell viability
Chondrocyte cultures were treated with DPI (concen-
trations ranging from 0.001 to 10 m M) for 2h prior to
the  addition  of  IL-1  (20ng/ml)  and  then  further
incubated  for  16h. After  collection  of  the  cell-free
supernatant for measurement of the nitrite concentra-
tion, the adherent cells were incubated, for 30min at
37°C,  with  a  solution  of  the  3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium (MTT) salt (500 m g/ml),
which on reduction originates dark blue crystals of
formazan.  Formazan  quantification  was  performed
using an automatic plate reader (SLT, Austria) set at a
test  wavelength  of  570nm  and  a  reference  wave-
length of 620nm. The amount of formazan produced
reflects the mitochondrial reducing  capacity of  the
cells and their viability.32
Measurement of reactive oxygen species
production
The intracellular production of reactive oxygen spe-
cies  was  measured  using  DCFH2-DA  as  described
previously33,34 with  modifications.  DCFH2-DA  is  a
non-fluorescent probe that, on diffusion into the cells,
is  hydrolyzed  by  intracellular  esterases  to
29 ,79 -dichlorodihydrofluorescein  (DCFH2),  which  is
trapped within the cells. In the presence of reactive
oxygen  species,  particularly  peroxides,  DCFH2 is
oxidized  to  the  highly  fluorescent  compound
29 ,79 -dichlorofluorescein.
Chondrocytes were loaded with 5 m M DCFH2-DA in
Na+ saline solution (140 mM of NaCl, 5 mM of KCl,
1.5 mM  of  CaCl2,  1.0 mM  of  MgCl2,  1.0 mM  of
NaH2PO4, 5.6 mM of glucose, 20.0 mM of Hepes; pH
7.4) for 20min at 37°C. After rinsing, the cells were
treated with the indicated concentrations of DPI for
30min.  Then,  IL-1  (20ng/ml)  was  added  to  the
corresponding wells and the cells further incubated
for another 30min. The fluorescence intensity of the
cells was measured immediately at 37°C using a SPEX
Fluorolog  spectrometer,  equipped  with  a  thermo-
stated waterbath, with excitation set at 502nm and
emission set at 550nm.
Results
The  supernatants  from  chondrocyte  cultures  pre-
treated  with  DPI,  in  concentrations  ranging  from
0.001 to 10m M, were used to evaluate NO produc-
tion, whereas the adherent cells were used to assess
the  effect  of  DPI  on  cell  viability. The  viability  of
chondrocytes in  culture  was  assessed by  the  MTT
reduction  assay,  as  described  previously.32 In  this
method,  the  optical  density  (O.D.)  of  the  solution
containing  the  formazan produced by  reduction  of
the MTT salt is measured spectrophotometrically. The
ability of IL-1-treated chondrocytes to reduce the MTT
salt was identical to that of cells cultured in control
conditions (0.379 ± 0.01 O.D. and 0.359 ± 0.02 O.D.,
respectively). The amount of formazan produced by
cells treated with 1 m M (0.358 ± 0.02 O.D.) or 10 m M
(0.361 ± 0.01 O.D.) of DPI did not change relatively to
that obtained in control cells. Likewise, the reducing
capacity of chondrocytes treated with 1m M (0.372 ±
0.01 O.D.) and 10 m M (0.377 ± 0.03 O.D.) of DPI in
the presence of IL-1 did not differ from that observed
both  in  control  and  in  IL-1-treated  chondrocytes.
These  results  show  that  DPI  did  not  affect  the
mitochondrial  reducing  capacity  of  chondrocytes
and, consequently, did not decrease the cell viability,
even at the highest concentration tested (10 m M).
Pretreatment  of  chondrocyte  cultures  with  DPI
dose-dependently inhibited IL-1-induced NO produc-
tion, as assessed by the amount of nitrites accumu-
lated  in  the  culture  supernatants  (Fig.  1A).  Fur-
thermore,  DPI  also  effectively  inhibited  NO
production when added to the cell cultures after IL-1
treatment (Fig. 1B). The concentrations required for
half-maximal inhibition of NO production were identi-
cal irrespective of  DPI being  added before (IC50 =
0.031 ± 0.004 m M) or after (IC50 = 0.039 ± 0.003m M)
IL-1 treatment, as shown in Fig. 1A,B, respectively.
Pretreatment  of  chondrocyte  cultures  with  DPI
dose-dependently inhibited IL-1-induced iNOS mRNA
(Fig. 2) and protein synthesis (Fig. 3). However, the
concentrations of DPI required for inhibition of iNOS
expression were higher than those that inhibited iNOS
activity. At a concentration of 10 m M, DPI decreased
iNOS mRNA and protein levels to approximately 10%
of those obtained in cells treated with IL-1 alone (Figs.
2  and  3),  whereas  a  concentration of  0.1 m M  was
DPI inhibits NF-k B activation
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production (Fig.  1).  DPI  alone did  not  affect iNOS
mRNA and protein levels, nor nitrite concentration,
relative to untreated cells (data not shown).
To further elucidate the mechanism by which DPI
reduced iNOS expression, its effect on IL-1-induced
NF-k B activation was evaluated. For this purpose, the
chondrocyte cultures  were  previously  treated  with
several concentrations of DPI (from 1 to 10 m M) as
indicated in Fig. 4, for 2h. Then, IL-1 (20ng/ml) was
added  to  the  cell  cultures,  which  were  further
incubated for  30min.  Electrophoretic mobility  shift
A. F. Mendes et al.
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FIG. 1. Effect of DPI on IL-1-induced NO production. (A) Chondrocyte cultures were pretreated with the indicated concentrations
of  DPI  for  2h.  Then,  IL-1 (20ng/ml)  was  added  to  the corresponding wells  and the  cells  further  incubated  for  16h.  (B)
Chondrocyte cultures were treated overnight with IL-1 (20ng/ml). Then, the culture supernatant was removed and the cells
washed three times with culture medium. New culture medium, containing the indicated concentrations of DPI, was added to
the corresponding plates and the cells further incubated for 16h. The nitrite concentration of each sample was determined as
described in Materials and methods. Each bar represents the mean ± SD of six independent experiments, each performed in
triplicate. * p < 0.01 relative to IL-1.
FIG. 2. Effect of DPI on IL-1-induced iNOS mRNA expression.
Chondrocyte  cultures  were  pretreated  with  the  indicated
concentrations of DPI for 2h. Then, IL-1 (20ng/ml) was added
and the cells  further incubated for  6h.  iNOS  and GAPDH
mRNAs  were  detected  by  Northern  blot,  as  described  in
Materials and methods. The results shown are representa-
tive of three independent experiments.assay  of  an  oligonucleotide  probe  containing  the
specific consensus binding sequence for NF-k B was
used  to  detect active  NF-k B  dimers  in  the  nuclear
extracts obtained from cells treated with IL-1, either
in the presence or absence of DPI. Nuclear extracts
from cells pretreated with DPI (concentrations rang-
ing  from  1  to  10 m M)  showed  a  dose-dependent
decrease of the intensity of the bands corresponding
to the NF-k B–DNA complexes (Fig. 4). At a concentra-
tion of 10 m M, DPI almost completely abolished IL-
1-induced  NF-k B  activation.  In  competition  assays,
performed by incubation of the nuclear extracts from
IL-1-treated cells with the [32P]-labeled NF-k B oligonu-
cleotide and a 100-fold excess of unlabeled probe, the
formation  of  protein-[32P]-labeled  oligonucleotide
complexes was completely abolished. Supershift anal-
ysis with an antibody against the p65 subunit of NF-k B
revealed the presence of this protein in the protein–
oligonucleotide complexes (Fig. 4).
Finally, DCFH2, a probe that becomes fluorescent on
oxidation,33,34 was used to measure both the produc-
tion of ROS in response to IL-1 and the ability of DPI to
inhibit ROS production in chondrocyte cultures. The
fluorescence intensity of  chondrocytes loaded with
DCFH2-DA was measured as described in Materials and
methods. The results in Fig. 5 show that IL-1 induced
the  production  of  ROS,  which  was  inhibited,  in  a
dose-dependent  manner,  by  pretreatment  of  the
chondrocyte  cultures  with  DPI.  Furthermore,  the
DPI inhibits NF-k B activation
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FIG.  3.  Effect  of  DPI  on  IL-1-induced  iNOS  protein  synthesis.  Chondrocyte  cultures  were  pretreated  with  the  indicated
concentrations of DPI for 2h. Then, IL-1 (20ng/ml) was added and the cells further incubated for 16h. iNOS and actin levels
were  detected  by  Western  blot,  as  described  in  Materials  and  methods.  The  results  shown  are  representative of  three
independent experiments.
FIG.  4.  Effect  of  DPI  on  IL-1-induced  NF-k B  activation.
Chondrocyte  cultures  were  pretreated  with  the  indicated
concentrations  of  DPI  for  2h  before  the  addition  of  IL-1
(20ng/ml)  for  30min.  The  nuclear  extracts,  prepared  as
described in Materials and methods, were used to detect NF-
k B binding to a specific oligonucleotide probe by EMSA. The
results  shown  are  representative  of  three  independent
experiments.
FIG. 5. Effect  of DPI on IL-1-induced ROS production. The
fluorescence  intensity  of  chondrocyte  cultures  preloaded
with  DCFH2-DA  was  measured  after  treatment  with  IL-1
(20ng/ml),  in  the  presence  or  absence  of  the  indicated
concentrations of DPI, as described in Materials and meth-
ods.  Results  are expressed as the percent increase of  the
fluorescence intensity relatively to control cells, which were
loaded with DCFH2-DA but otherwise left untreated. Each bar
represents the mean ± SD of three independent experiments,
each performed in triplicate.* p < 0.05 relative to IL-1.concentrations of DPI that suppressed ROS produc-
tion were also effective in inhibiting NF-k B activation
and iNOS expression.
Discussion
The  results  presented  show  that  DPI  effectively
inhibited NO production induced by IL-1 in primary
cultures  of  articular  chondrocytes  (Fig.  1A,B). The
ability  of  DPI  to  suppress  NO  production  was
identical  either  when  added  to  the  chondrocyte
cultures  before  or  after  IL-1  treatment  (Fig.  1A,B),
indicating that this compound inhibited the activity of
the NOS enzyme. These results are in agreement with
previous studies that demonstrated the ability of DPI
to inhibit NOS activity by irreversibly binding to its
flavin component.26–28
The results presented in Figs. 2 and 3 demonstrate
that DPI (1–10 m M) also blocked, in a dose-depend-
ent manner, IL-1-induced iNOS upregulation at both
the mRNA and protein levels. Thus, DPI inhibits IL-
1-induced NO production in primary bovine articu-
lar chondrocytes acting by two distinct mechanisms:
(i)  inhibition  of  IL-1-induced  iNOS  upregulation  by
acting at the transcriptional level; and (ii) inhibition
of iNOS activity. Nevertheless, the concentrations of
DPI required for inhibition of iNOS expression (Figs.
2 and 3)  are higher than those sufficient to inhibit
the  enzyme  activity  (Fig.  1),  indicating  that  the
mechanism underlying induction of iNOS expression
is less sensitive to inhibition by DPI than the iNOS
enzyme itself.
Electrophoretic mobility shift assay (EMSA) analysis
showed that DPI prevented IL-1-induced NF-k B activa-
tion  in  concentrations  that  also  inhibited  iNOS
expression (Fig. 4). These results strongly suggest that
DPI prevents IL-1-induced iNOS expression by inhibit-
ing NF-k B activation. These results are in agreement
with a recent report showing that DPI inhibited NF-k B
activation and group IIA phospholipase A2 expression
induced by IL-1 and TNF-a in rat mesangial cells.29
In  recent  years,  reactive  oxygen  species  (ROS)
have been increasingly recognized as signaling inter-
mediates  for  many  cytokine-  and  growth  factor-
induced responses in various cell types.22,35,36 ROS
have been shown to regulate  many  cellular  events,
including  activation of transcription factors, namely
NF-k B,37–40 induction  of  gene  transcription22,35,41
and  cell  death.42,43 In chondrocytes, IL-1  has  been
shown  to  induce  the  production  of  ROS,  which
were reported to mediate IL-1-induced expression of
c-fos and collagenase.22
The  flavonoid-containing  enzymes  sensitive  to
inhibition by DPI are sources of cellular ROS produc-
tion.24 Thus, most effects of DPI and other iodonium
compounds have been attributed to the suppression
of  ROS  production,  usually  interpreted as  resulting
from the inhibition of NADPH oxidase.22,44–47
The results presented in Fig. 5 show that DPI dose-
dependently inhibited IL-1-induced ROS production,
therefore  indicating  that  flavonoid-containing
enzymes are required for IL-1-induced ROS  produc-
tion  in  articular  chondrocytes.  Furthermore,  our
results  also  indicate  that  the  ROS  produced  in
response  to  IL-1  mediate  and  are  required  for  the
activation of NF-k B, which in turn is necessary for the
transcriptional  induction  of  iNOS  expression  in
bovine articular chondrocytes (Figs. 2–4).
Whether the inhibitory effects of DPI result from
the  inhibition  of  NADPH  oxidase  and/or  of  other
flavonoid-containing enzymes was not addressed in
the present study. Nevertheless, we observed that the
reducing capacity of chondrocyte’s mitochondria, as
evaluated  by  the  MTT  reduction  assay,  was  not
affected by DPI treatment, indicating that mitochon-
drial  flavonoid-containing  enzymes,  such  as  NADH
dehydrogenase, were not inhibited by DPI. Therefore,
mitochondrial flavonoid-containing enzymes are not
likely to contribute to IL-1-induced ROS production in
articular chondrocytes, since the generation of ROS
was completely inhibited by DPI (Fig. 5). In turn, this
observation favors the involvement of plasma mem-
brane-bound  flavonoid-containing enzymes, such as
NADPH  oxidase,  on  IL-1-induced  ROS  production
and on the subsequent activation of NF-k B and iNOS
expression.
It is interesting to notice that the concentrations
of DPI (1–10 m M) that were effective in inhibiting IL-
1-induced  ROS  production (Fig.  5)  were  also  suffi-
cient  to inhibit  NF-k B  activation (Fig.  4)  and iNOS
expression (Fig. 2), whereas much lower concentra-
tions  of  DPI  completely  abolished  the  activity  of
iNOS (Fig. 1). Together, these results suggest that the
flavonoid-containing  enzymes,  involved  in  IL-
1-induced ROS production and underlying induction
of  NF-k B  activation  and  iNOS  expression,  are  less
sensitive to inhibition by DPI than the iNOS enzyme
itself.
Studies in vivo showed that DPI effectively  sup-
pressed the development of inflammatory arthritis in
mice, which was attributed to its ability to simulta-
neously  inhibit  NADPH  oxidase  and  NOS.48 In  the
present study, the intracellular mechanisms that can
explain, at least in part, the reported efficacy of DPI
in  the  treatment  of  inflammatory  arthritis  were
investigated  for  the  first  time.  These  mechanisms
involve,  on  one  hand, the  ability  of  DPI  to  inhibit
ROS production and, subsequently, the activation of
NF-k B and the expression of NF-k B-dependent genes
such  as  iNOS,  and,  on  the  other  hand,  the  direct
inhibition  of  iNOS  activity.  Therefore,  adequate
manipulation  of  the  dosage  regimen  of  DPI  may
allow for the selective inhibition of iNOS expression
and/or activity.
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